Alex Nemiroff

Alex Nemiroff, listed as senior executive, appears in our data through filings on Praxis Precision Medicines, Inc. shares, published by SEC (Form 4). We count 31 filings; the first trade dates from 12 February 2021 and the latest from 12 January 2026.

The open-market side counts 1 purchase for €12k alongside 5 sales for €4.8M. On balance, insiders were net sellers of €4.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 19 share grants and 6 option exercises.

On 13 January 2026 came the latest disclosure, a share grant for €182k in Praxis Precision Medicines, Inc. The last insider purchase was made public on 14 June 2022, 1,593 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.